Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis ...Middle East

SHANGHAI, Sept. 19, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines in Greater China and other parts of Asia, announced today that the Center...

Hence then, the article about everest medicines announces china center for drug evaluation of nmpa recommends priority review for cefepime taniborbactam for the treatment of complicated urinary tract infections including pyelonephritis was published today ( Wednesday 20/09/2023 - 03:24 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis )

Also on site :

• US cable outlines new ‘construct’ to control Strait of Hormuz – media
• Could the US-Iran war become a protracted ‘frozen’ conflict?
• Why The 'Fluxury' Trend Is The Smartest New Way To Travel This Summer